Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort
Background: There are limited data on the outcomes of rechallenge with anti-tuberculosis therapy (ATT) following anti-tuberculosis drug-induced liver injury (AT-DILI) in a high HIV prevalence setting. Objectives: To describe the outcomes of rechallenge with first-line ATT. Method: Hospitalised parti...
Saved in:
Main Authors: | Muhammed Shiraz Moosa (Author), Gary Maartens (Author), Hannah Gunter (Author), Shaazia Allie (Author), Mohamed F. Chughlay (Author), Mashiko Setshedi (Author), Sean Wasserman (Author), David F. Stead (Author), Karen Cohen (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023) -
<i>Helicobacter pylori</i> Infection: Antibiotic Resistance and Solutions for Effective Management in Africa
by: Mashiko Setshedi, et al.
Published: (2023) -
Challenges in PARP inhibitor therapy: A case of Olaparib-induced liver injury and successful rechallenge with Niraparib
by: Kai Zhu, et al.
Published: (2024) -
Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions
by: J.M. Pinazo-Bandera, et al.
Published: (2024) -
Changing trends and the impact of alcohol on the HIV/AIDS epidemic in South Africa: Review
by: Mashiko Setshedi, et al.
Published: (2011)